Since all PTLD patients in our cohort were CMV-seropositive, we set out to examine whether CMV skews the NK cell repertoire toward late-differentiated cells at the expense of CD56dimNKG2A+KIR− NK cells. The gene discussed is KIR3DL1; the disease is post-transplant lymphoproliferative disease.